19-16889579-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003950.4(F2RL3):c.116C>T(p.Thr39Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000459 in 1,570,078 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/14 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_003950.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
F2RL3 | NM_003950.4 | c.116C>T | p.Thr39Met | missense_variant | 2/2 | ENST00000248076.4 | NP_003941.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
F2RL3 | ENST00000248076.4 | c.116C>T | p.Thr39Met | missense_variant | 2/2 | 1 | NM_003950.4 | ENSP00000248076.2 | ||
F2RL3 | ENST00000599210.1 | c.112C>T | p.Arg38Cys | missense_variant, splice_region_variant | 2/2 | 2 | ENSP00000471518.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152196Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000544 AC: 12AN: 220624Hom.: 0 AF XY: 0.0000670 AC XY: 8AN XY: 119444
GnomAD4 exome AF: 0.0000473 AC: 67AN: 1417882Hom.: 0 Cov.: 32 AF XY: 0.0000514 AC XY: 36AN XY: 700192
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152196Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74344
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 11, 2024 | The c.116C>T (p.T39M) alteration is located in exon 2 (coding exon 2) of the F2RL3 gene. This alteration results from a C to T substitution at nucleotide position 116, causing the threonine (T) at amino acid position 39 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at